A mid-size Cell and Gene Therapy biotech is developing AAV based gene therapies for rare diseases. In order to move one of their assets into the clinic, our client needed a partner to take on the development of this asset. Thus, Kineticos was brought on to be their third-party business development arm to identify potential partners for licensing of this asset across the globe.

Gene Therapy Business Development Support

For the full case study including example deliverables, click here: Gene Therapy Business Development Support

Subscribe to the Kineticos Research Institute to receive weekly emails containing insightful content.